Literature DB >> 19139816

Correlation of tumor topography and peritumoral edema of recurrent malignant gliomas with therapeutic response to intranasal administration of perillyl alcohol.

Clovis O Da Fonseca1, Julio Thome Silva, Igor Rodrigo Lins, Marcela Simão, Adriano Arnobio, Débora Futuro, Thereza Quirico-Santos.   

Abstract

BACKGROUND: The aim of this study was to establish a correlation of tumor topography and peritumoral brain edema with the therapeutic response to intranasal administration of perillyl alcohol (POH) in a cohort of patients with recurrent malignant gliomas.
METHODS: The retrospective study reviewed clinical and neuroradiological data from patients with recurrent malignant gliomas who received intranasal daily administration of POH 440 mg. The following parameters were assessed: demographic characteristics, initial symptoms, overall survival, tumor topography and tumor size, presence of midline shift and extent of peritumoral edema. Statistical analysis was carried out with log rank tests and overall survival as assessed by Kaplan-Meier method including 95% confidence intervals.
RESULTS: A cohort of 67 patients included 52 (78%) with glioblastoma (GBM), ten (15%) with anaplastic astrocytoma (AA) and five (7%) with anaplastic oligodendroglioma (AO). Accordingly to tumor topography lobar localization was present in all (5/5) AO; eight (8/10) and 41 GBM patients whereas in the basal ganglia two AA and 11 GBM patients. It was also observed a relation between the tumor size and area of peritumoral brain edema (PTBE). Patients with good therapeutic response showed reduction of tumor size and PTBE area, but poor prognosis was associated with lack of response to treatment and persistence of high PTBE. Patients with tumor in the basal ganglia survived significantly longer than those with lobar gliomas (log rank test, p = 0.0003). Presence of midline shift (>1 cm) was a statistically significant risk factor for shorter survival (log rank test, p = 0.0062)
CONCLUSIONS: This study suggests that: (1) patients with recurrent gliomas with localization in the basal ganglia survive significantly longer than those with tumors at lobar localization; (2) presence of PTBE contributes to symptoms, likely to be implicated in the morbidity and invading potential of malignant gliomas. These findings support the theory that interaction between glioma cells at distinct brain microenvironment can influence the oncobiological behavior of glioma cells and ultimately to the prognosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19139816     DOI: 10.1007/s10637-008-9215-3

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  25 in total

1.  Prognostic significance of preoperative MRI scans in glioblastoma multiforme.

Authors:  M A Hammoud; R Sawaya; W Shi; P F Thall; N E Leeds
Journal:  J Neurooncol       Date:  1996-01       Impact factor: 4.130

Review 2.  Surgery for malignant gliomas: mechanistic reasoning and slippery statistics.

Authors:  Patrick Mitchell; David W Ellison; A David Mendelow
Journal:  Lancet Neurol       Date:  2005-07       Impact factor: 44.182

Review 3.  Anaplastic oligodendroglioma responding favorably to intranasal delivery of perillyl alcohol: a case report and literature review.

Authors:  Clovis O Da Fonseca; Marcos Masini; Débora Futuro; Regina Caetano; Cerli Rocha Gattass; Thereza Quirico-Santos
Journal:  Surg Neurol       Date:  2006-07-21

Review 4.  Recent advances in the molecular genetics of malignant gliomas disclose targets for antitumor agent perillyl alcohol.

Authors:  Clovis Orlando da Fonseca; José Alberto Landeiro; Steven S Clark; Thereza Quirico-Santos; Maria da Gloria da Costa Carvalho; Cerli Rocha Gattass
Journal:  Surg Neurol       Date:  2006

5.  Changes in fiber integrity, diffusivity, and metabolism of the pyramidal tract adjacent to gliomas: a quantitative diffusion tensor fiber tracking and MR spectroscopic imaging study.

Authors:  A Stadlbauer; C Nimsky; S Gruber; E Moser; T Hammen; T Engelhorn; M Buchfelder; O Ganslandt
Journal:  AJNR Am J Neuroradiol       Date:  2007-03       Impact factor: 3.825

6.  The prognostic significance of midline shift at presentation on survival in patients with glioblastoma multiforme.

Authors:  E S Gamburg; W F Regine; R A Patchell; J M Strottmann; M Mohiuddin; A B Young
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-12-01       Impact factor: 7.038

7.  [Outcome of surgical treatment of malignant astrocytoma of the brain].

Authors:  Goran Pavlićević; Zoran Roganović
Journal:  Vojnosanit Pregl       Date:  2003 Mar-Apr       Impact factor: 0.168

8.  Caveolin-1 expression is variably displayed in astroglial-derived tumors and absent in oligodendrogliomas: concrete premises for a new reliable diagnostic marker in gliomas.

Authors:  Paola Cassoni; Rebecca Senetta; Isabella Castellano; Erika Ortolan; Martino Bosco; Ivana Magnani; Alessandro Ducati
Journal:  Am J Surg Pathol       Date:  2007-05       Impact factor: 6.394

9.  Glioblastoma multiforme in skin: a report of 2 cases and review of the literature.

Authors:  Mark Mentrikoski; Mahlon D Johnson; David N Korones; Glynis A Scott
Journal:  Am J Dermatopathol       Date:  2008-08       Impact factor: 1.533

10.  Peritumoral edema and karyometric variables in astrocytoma of the brain.

Authors:  A Kostic; D Mihailovic; S Veselinovic; G Tasic; D Radulovic; I Stefanovic
Journal:  J BUON       Date:  2007 Apr-Jun       Impact factor: 2.533

View more
  12 in total

1.  The anticancer drug perillyl alcohol is a Na/K-ATPase inhibitor.

Authors:  Diogo G Garcia; Lidia M F Amorim; Mauro V de Castro Faria; Aline S Freire; Ricardo E Santelli; Clóvis O Da Fonseca; Thereza Quirico-Santos; Patricia Burth
Journal:  Mol Cell Biochem       Date:  2010-08-06       Impact factor: 3.396

Review 2.  A systematic review of inhaled intranasal therapy for central nervous system neoplasms: an emerging therapeutic option.

Authors:  Asa Peterson; Amy Bansal; Florence Hofman; Thomas C Chen; Gabriel Zada
Journal:  J Neurooncol       Date:  2014-01-08       Impact factor: 4.130

3.  Efficacy of monoterpene perillyl alcohol upon survival rate of patients with recurrent glioblastoma.

Authors:  Clovis O da Fonseca; Marcela Simão; Igor R Lins; Regina O Caetano; Débora Futuro; Thereza Quirico-Santos
Journal:  J Cancer Res Clin Oncol       Date:  2010-04-18       Impact factor: 4.553

4.  Analysis of EGF+61A>G polymorphism and EGF serum levels in Brazilian glioma patients treated with perillyl alcohol-based therapy.

Authors:  Francisco das Chagas Abreu da Silveira; Bruno de Almeida Lopes; Clovis Orlando da Fonseca; Thereza Quirico-Santos; Izabel Christina Nunes de Palmer Paixão; Lidia Maria da Fonte de Amorim
Journal:  J Cancer Res Clin Oncol       Date:  2012-04-06       Impact factor: 4.553

5.  Efficacy of a ketogenic diet with concomitant intranasal perillyl alcohol as a novel strategy for the therapy of recurrent glioblastoma.

Authors:  Juliana Guimarães Santos; Wanise Maria Souza Da Cruz; Axel H Schönthal; Marcela D'alincourt Salazar; Cristina Asvolinsque Pantaleão Fontes; Thereza Quirico-Santos; Clovis Orlando Da Fonseca
Journal:  Oncol Lett       Date:  2017-11-08       Impact factor: 2.967

Review 6.  Novel therapeutic delivery approaches in development for pediatric gliomas.

Authors:  Katherine E Warren
Journal:  CNS Oncol       Date:  2013-09

Review 7.  Targeting Ras-RAF-ERK and its interactive pathways as a novel therapy for malignant gliomas.

Authors:  Hui-Wen Lo
Journal:  Curr Cancer Drug Targets       Date:  2010-12       Impact factor: 3.428

8.  Intranasal administration of the chemotherapeutic perillyl alcohol results in selective delivery to the cerebrospinal fluid in rats.

Authors:  Geetika Nehra; Shannon Andrews; Joan Rettig; Michael N Gould; Jill D Haag; Steven P Howard; Robert G Thorne
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

9.  Adjuvant effect of low-carbohydrate diet on outcomes of patients with recurrent glioblastoma under intranasal perillyl alcohol therapy.

Authors:  Juliana Guimaraes Santos; Gisele Faria; Wanise Da Cruz Souza Da Cruz; Cristina Asvolinsque Fontes; Axel H Schönthal; Thereza Quirico-Santos; Clovis O da Fonseca
Journal:  Surg Neurol Int       Date:  2020-11-11

10.  Expression of brain-specific angiogenesis inhibitor 1 is inversely correlated with pathological grade, angiogenesis and peritumoral brain edema in human astrocytomas.

Authors:  Wei Wang; Rong DA; Maode Wang; Tuo Wang; Lei Qi; Haitao Jiang; Wei Chen; Qi Li
Journal:  Oncol Lett       Date:  2013-03-12       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.